These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15056379)

  • 21. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells].
    Yang WL; Cui H; Feng J; Chang XH; Fu TY; Ye X; Zhang H; Li XP; Wen HW; Feng LM; Tong CR
    Ai Zheng; 2004 Dec; 23(12):1639-45. PubMed ID: 15601552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects.
    Semana G; Gausling R; Jackson RA; Hafler DA
    J Autoimmun; 1999 Jun; 12(4):259-67. PubMed ID: 10330297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T cell proliferative responses to particulate microbial antigens are supported by populations enriched in dendritic cells.
    Mittal A; Nath I
    Clin Exp Immunol; 1987 Sep; 69(3):611-7. PubMed ID: 3311498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent T cell anergy in human type 1 diabetes.
    Dosch H; Cheung RK; Karges W; Pietropaolo M; Becker DJ
    J Immunol; 1999 Dec; 163(12):6933-40. PubMed ID: 10586096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous mixed lymphocyte reaction in newly diagnosed type-1 diabetes.
    Knospe S; Köhler E; Rjasanowski I; Titze K
    Exp Clin Endocrinol; 1990 Feb; 95(1):148-56. PubMed ID: 2139849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A proinsulin 74-90-derived protease-resistant, altered peptide ligand increases TGF-beta 1 secretion in PBMC from patients with type 1 diabetes mellitus.
    van Aalst D; Kalbacher H; Palesch D; Zou F; Spyrantis A; Rosinger S; Boehm BO; Burster T
    J Leukoc Biol; 2010 May; 87(5):943-8. PubMed ID: 20110445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines.
    Michiels A; Tuyaerts S; Bonehill A; Corthals J; Breckpot K; Heirman C; Van Meirvenne S; Dullaers M; Allard S; Brasseur F; van der Bruggen P; Thielemans K
    Gene Ther; 2005 May; 12(9):772-82. PubMed ID: 15750615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse.
    Kadri N; Potiron N; Ouary M; Jegou D; Gouin E; Bach JM; Lieubeau B
    Immunol Lett; 2007 Feb; 108(2):129-36. PubMed ID: 17196260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
    Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory.
    Upham JW; Rate A; Rowe J; Kusel M; Sly PD; Holt PG
    Infect Immun; 2006 Feb; 74(2):1106-12. PubMed ID: 16428758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dysfunction of peripheral blood dendritic cells in patients with mixed connective tissue disease.
    Akiyama Y; Suzuki T; Hara K; Ishibashi T; Katagiri T; Imai F; Ohno S; Tanaka M; Dohi Y
    Arerugi; 1993 Jun; 42(6):766-72. PubMed ID: 8347095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
    Faresjö MK; Vaarala O; Thuswaldner S; Ilonen J; Hinkkanen A; Ludvigsson J
    Diabetes Metab Res Rev; 2006; 22(6):462-70. PubMed ID: 16572494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and functional characterization of mature dendritic cells from pediatric cancer patients.
    Jacobs JF; Hoogerbrugge PM; de Rakt MW; Aarntzen EH; Figdor CG; Adema GJ; de Vries IJ
    Pediatr Blood Cancer; 2007 Dec; 49(7):924-7. PubMed ID: 17486645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation.
    Vasir B; Borges V; Wu Z; Grosman D; Rosenblatt J; Irie M; Anderson K; Kufe D; Avigan D
    Br J Haematol; 2005 Jun; 129(5):687-700. PubMed ID: 15916692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro].
    Xing LH; Wang FS; Zhu CL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):365-8. PubMed ID: 15340554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
    Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells.
    White KL; Rades T; Furneaux RH; Tyler PC; Hook S
    J Pharm Pharmacol; 2006 Jun; 58(6):729-37. PubMed ID: 16734974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.